CC

Chemours Co Materials Chemicals & Allied Products Russell 3000
$13.53Close $2.0BMarket cap $10.33 – $27.6852-week range Nov 2, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 3 of 8 trend conditions
  • Lagging the market RS 15 · weaker than 85% of stocks over 12 months
  • Far from its high 51% below its 52-week high
  • Results soon Nov 2, 2026, in 1 day
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 5, 2026
Off 12-month high 51%
1wk up 5.6% price change
1mo down 0.3% price change
12-month return up 5% market up 11% · its own down 10%
F-score 4 / 9 Weak
Altman Z 1.40 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 8.1× price / book
Earnings yield down 0.1% EBIT / enterprise value
Cheaper than 29% of the market · expensive
Revenue growth 0% year on year
EPS growth — latest quarter
Sales growth down 1% latest quarter · -2 pts
ROE down 94% return on equity
Free cash margin up 1% $51.0M FCF
D/E 16.40 long-term debt / equity
Net debt / EBITDA 10.3×
Interest cover Lossoperating loss
Piotroski tests
  • not yet profitable on its assets
  • profitability slipped from last year
  • took on more long-term debt
  • issued more shares
  • gross margin narrowed
  • generating cash from operations
  • profits backed by cash
  • short-term liquidity improved
  • assets working harder

Repair signals

  • FCF turned positive ($-993M → $51M)
  • Revenue reaccelerating (-5% then +0%)

Trade setup

ATR% 3.7% $0.50 a day · 2×ATR $12.54
RS 15 / 99 vs the universe
Trend 3 / 8 trend template
Relative volume 1.1× vs 50-day average
Up/down volume 0.83 50 sessions
Implied move — no option chain · report Nov 2, 2026
Trend template · 3 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: passes
  • 50-day average above the 150 and 200-day: fails
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: passes
  • Within 25% of the 52-week high: fails
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

4 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
  • Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
  • Heavily indebted Net debt is 10.3 times EBITDA — roughly 10 years of earnings before interest, tax and depreciation to repay borrowings in full.
  • Gross margin narrowing Gross margin fell from 19.8% to 15.5%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Aug 4, 2026
Last shock Aug 5, 2026-19% in one session3.9× volumeon results-7% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $5.8B +0.4% on FY2024
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $5.0B FY2021 · $6.3B FY2022 · $6.8B FY2023 · $6.1B FY2024 · $5.8B FY2025 · $5.8B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$386.0M down to a loss
-$500M $0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $219.0M FY2021 · $608.0M FY2022 · $578.0M FY2023 · -$253.0M FY2024 · $69.0M FY2025 · -$386.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $51.0M back to a profit
-$1B $0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $540.0M FY2021 · $537.0M FY2022 · $448.0M FY2023 · $186.0M FY2024 · -$993.0M FY2025 · $51.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 16%
  • Net -7%
  • Free cash 1%
-20% 0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 21% · Net 4% · Free cash 11% FY2021 · Gross 22% · Net 10% · Free cash 8% FY2022 · Gross 24% · Net 8% · Free cash 7% FY2023 · Gross 21% · Net -4% · Free cash 3% FY2024 · Gross 20% · Net 1% · Free cash -17% FY2025 · Gross 16% · Net -7% · Free cash 1%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $3.4B net debt
  • Cash
  • Long-term debt
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $1.1B · Long-term debt $4.0B FY2021 · Cash $1.5B · Long-term debt $3.7B FY2022 · Cash $1.1B · Long-term debt $3.6B FY2023 · Cash $1.2B · Long-term debt $4.0B FY2024 · Cash $713.0M · Long-term debt $4.1B FY2025 · Cash $670.0M · Long-term debt $4.1B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 149.89m -9.1% since FY2020
164.92m 148.50m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 164.92m FY2021 · 161.05m FY2022 · 148.50m FY2023 · 148.59m FY2024 · 149.43m FY2025 · 149.89m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $5.0B $6.3B $6.8B $6.1B $5.8B $5.8B
Gross margin 21% 22% 24% 21% 20% 16%
Net income $219.0M $608.0M $578.0M -$253.0M $69.0M -$386.0M
Net margin 4% 10% 8% -4% 1% -7%
Earnings per share $1.32 $3.60 $3.65 -$1.70 $0.46 -$2.57
Free cash flow $540.0M $537.0M $448.0M $186.0M -$993.0M $51.0M
Free cash margin 11% 8% 7% 3% -17% 1%
Cash $1.1B $1.5B $1.1B $1.2B $713.0M $670.0M
Long-term debt $4.0B $3.7B $3.6B $4.0B $4.1B $4.1B
Shareholders' equity $813.0M $1.1B $1.1B $721.0M $571.0M $250.0M
Shares outstanding 164.92m 161.05m 148.50m 148.59m 149.43m 149.89m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jun 30, 2026 36d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Feb 24, 2026 Annual ↗ Dec 31, 2025 55d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 6, 2025 Quarterly ↗ Mar 31, 2025 36d
Feb 18, 2025 Annual ↗ Dec 31, 2024 49d
Nov 4, 2024 Quarterly ↗ Sep 30, 2024 35d
Aug 1, 2024 Quarterly ↗ Jun 30, 2024 32d
Apr 30, 2024 Quarterly ↗ Mar 31, 2024 30d
Mar 27, 2024 Annual ↗ Dec 31, 2023 87d
Oct 27, 2023 Quarterly ↗ Sep 30, 2023 27d

Current reports